NCT07114224View on ClinicalTrials.gov

Aβ PET and Tau PET Imaging in the Diagnosis and Progression Assessment of Alzheimer's Disease

NANot yet recruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

August 15, 2025

Primary Completion Date

June 1, 2027

Study Completion Date

June 1, 2027

Conditions
Alzheimer Disease (AD)Cognitive Dysfunction, Cognitive DisorderPET Imaging
Interventions
DIAGNOSTIC_TEST

AV45/AV-1、AV1451 PET

"Use PET equipment to collect multimodal imaging data. Sixty to ninety minutes after intravenous injection of 3.7 MBq/kg of 18F-AV45 or 18F-AV1, perform PET imaging in list mode to simultaneously collect structural and functional information under the same pathophysiological conditions.~The next day, perform 18F-AV1451 PET imaging to obtain tau protein distribution information."

All Listed Sponsors
lead

Xijing Hospital

OTHER

NCT07114224 - Aβ PET and Tau PET Imaging in the Diagnosis and Progression Assessment of Alzheimer's Disease | Biotech Hunter | Biotech Hunter